Should justices uphold it, the federal law could weaken parts of Virginia’s pending constitutional amendment to protect reproductive rights.
The Supreme Court temporarily preserved telehealth access to the abortion drug mifepristone Thursday until an appeals court can rule on a legal challenge to the medication the state of Louisiana filed against the U.S. Food and Drug Administration.
The result could have national implications by outlawing the mailing of mifepristone — even in states without abortion bans, like Virginia.
While the Supreme Court has allowed mifepristone to continue to be mailed for now, one of the dissenting justices, Clarence Thomas, cited a long-dormant 1873 law that blocks mailing “every article or thing designed, adapted, or intended for producing abortion, or for any indecent or immoral use.”
Abortion opponents have long considered that law, dubbed the Comstock Act, as a possible vehicle to enact a national ban of the procedure. One of them, activist Mark Lee Dickson, has traveled the country to persuade local governments to pass ordinances to apply the defunct law.
“If enforced, it would have the same impact as a national ban on abortion,” he said in 2024. “That is because it is a de-facto national abortion ban.”
The mailing of mifepristone “could easily be described as the largest drug-trafficking operation in the history of the United States,” Dickson said last week, adding that mailing the medication should cease in order to “restore the rule of law in this country.”
Meanwhile, telehealth company Hey Jane can continue to operate for the time being.
The company launched in Virginia in 2023 and currently serves 23 states. In an email, co-founder Kiki Freedman described their role as a crucial conduit for people seeking reproductive healthcare.
“For many patients, especially those facing cost, travel, or privacy barriers, it is the only way they can access care,” she said. “When telehealth access is restricted, countless patients are left without care altogether.”
Legal limbo nationally, some state certainty pending
Though further action by the appeals court, FDA or Supreme Court could affect mifepristone specifically, Virginia’s pending amendment, if passed, would still protect other avenues to abortion.
Abortion is currently legal in Virginia but it is not constitutionally protected. Embedding the right to the procedure into the state constitution would make access less subject to partisan turnover in state politics.
It would also mean that if telehealth abortions are outlawed federally, Virginians and people who travel could still get abortions.
But the referendum, too, is mired in lawsuits.
One challenges the ballot language as “misleading” to voters and seeks a rewrite ahead of November. Another claims that the constitutional amendment process was not fully followed in advancing the referendum, but a new post-facto law could invalidate that claim.
With the stay rooted in a lower court’s ruling on the mifepristone challenge’s merits, and other legal challenges, and the Food and Drug Administration’s new review of mifepristone, things could change in the months or year ahead.
State Sen. Jennifer Boysko, D-Fairfax, who sponsored the amendment, said it’s “exactly why” Democratic state lawmakers had pressed for the referendum.
“We cannot rely on the federal government anymore to protect us,” she said.
Repeal efforts
Though it’s unlikely to advance this year amid GOP majorities in Congress, U.S. Rep. Jennifer McClellan, D-Richmond is again leading an effort to repeal Comstock Act provisions.
In 2024, she and now-Gov. Abigail Spanberger — then still a member of congress — had carried legislation to remove abortion components from the act. Theirs joined four previous unsuccessful attempts.
“We will still try,” McClellan said in a call last week.
She emphasized the health implications of continuing some pregnancies and how mifepristone is also used for safe miscarriage management to prevent deadly infection. She added that defending reproductive healthcare access is a “campaign issue” amid congressional midterms this year.
Virginians will soon be able to weigh in on the pending constitutional amendment to enshrine abortion, contraception and fertility treatment access, which McClellan had also worked for years to advance as a state senator before joining Congress.
“Sometimes it takes years and years to get policy changed,” Boysko said.
Virginians will choose their congressional representatives Nov. 4, and on the same day will decide the fate of the reproductive rights amendment. Early voting will run from Sept. 18 to Oct. 31.